Vortrag anlässlich der Verleihung der Salomon-Neumann-Medaille an den Gemeinsamen Bundesausschuss (G-BA)

Literatur

• 1 Rotstein D, Laupacis A. Differences between systematic reviews and health technology assessments: A trade-off between the ideals of scientific rigor and the realities of policy making.  International Journal of Technology Assessment in Health Care. 2004;  20 177-183
• 2 http://www.g-ba.de/cms/front_content.php?idcat=19 , (geprüft 29.09.2006)
• 3 Marcia A. The Truth About the Drug Companies.  , How They Deceive Us and What to Do About It. Random House 2004 (dt. Übersetzung Der Pharma Bluff. Wie innovativ die Pillenindustrie wirklich ist. Kompart 2005)
• 4 Kassirer JP. On The Take. How Medicine's complicity with big business can endanger your health. Oxford University Pres 2005
• 5 Avorn J. Powerful Medicines. The Benifit, Risks and Costs of Prescription Drugs. Alfred A Knopf, New York 2004
• 6 Deyo RA, Patrick DL. Hope or Hype. The Obsession with Medical Advances and the High Cost of False Premises. Amacon 2005
• 7 Sackett DL. The Arrogance of preventive medicine.  Journal of the Canadian Medical Association. 2002;  167 363-364
• 8 King M, Nazareth I, Lampe F, Bower P, Chancler M, Morou M, Sibbald B, Lai R. Conceptual framework and systematic review of the effect of participants' and professionals' preferences in randomised controlled trials.  Health Technology Assessment. 2005;  35 1-186 , iii-iv
• 9 Devereaux PJ, Bhandari M, Clarke M, Montori VM, Cook DJ, Yusuf S, Sackett DL, Cinà CS, Walter SD, Haynes B, Schünemann HJ, Norman GR, Guyatt GH. The need for expertise-based randomised controlled trials.  BMJ. 2005;  330 88-92
• 10 McCulloch P, Taylor I, Sasako M, Lovett B, Griffin D. Randomised trials in surgery: problems and possible solutions.  British Medical Journal. 2002;  324 1448-1451
• 11 Moseley JB, O'Malley K, Petersen NJ, Menke TJ, Brody BA, Kuykendall DH, Hollingswort JC, Ashton CM, Wray NP. A controlled trial of arthroscopic surgery for osteoarthritis in the knee.  New England Journal of Medicine. 2002;  347 81-88
• 12 http://www.aerztezeitung.de/docs/2003/09/30/175a0203.asp , (geprüft 29.09.2006)
• 13 http://www.aerztezeitung.de/docs/2003/09/30/175a0501.asp , (geprüft 29.09.2006)
• 14 Basel Stent Cost-Effectiveness Trial-Late Thrombotic Events Trial.  ,  www.springerlink.com/content/g206723g421658j8/ geprüft 29.09.2006
• 15 http://www.meduniqa.at/3274.98.html , (geprüft 29.09.2006)
• 16 http://www.meduniqa.at/3274.98.html , (geprüft 29.09.2006)
• 17 Gabbay J, Walley T. Introducing new health interventions.  British Medical Journal. 2006;  332 64-65
• 18 Dent THS, Sadler M. From guidance to practice: Why NICE is not enough.  British Medical Journal. 2002;  324 842-855
• 19 Draborg E, Kronborg Andersen K. Recommendations in health technology assessments worldwide.  International Journal of Technology Assessment in Health Care. 2006;  22 155-160
• 20 Oliver S, Clarke-Jones L, Rees R, Milne R, Buchanan P, Gabbay G, Oakley A, Stein K. Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach.  Health Technology Assessment. 2004;  15 1-148 , III-IV
• 21 Henshall C, Koch P, Below GC, Boer A, Conde-Olagasasti JL, Dillon A, Gibis B, Grilli R, Hardy C, Liaropoulos L, Martin-Moreno JM; Roine R, Scherste R, Soreide O, Züllig M. Health technology assessment in policy and practice. Working Group 6 report.  International Journal of Technology Assessment in Health Care. 2002;  18 447-455
• 22 Lehoux P, Tailliez S, Denis JL, Hivon M. Redefining health technology assessment in Canada: Diversification of products and contextualization of findings.  International Journal of Technology Assessment in Health Care. 2004;  20 325-336
• 23 Schmacke N. Innovationen in der Medizin: das magische Dreieck von Evidenz, Werten und Ressourcen.  Zeitschrift für qualitative Bildungs-, Beratungs- und Sozialforschung. 2004;  5 331-353

Korrespondenzadresse